Duygu Mert

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Urinary Tract Infection

Hematopoietic Stem Cell

Chronic Lymphocytic Leukemia

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Turkish journal of medical sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Duygu Mert, Gulsen Iskender, Servet Kolgelier, Mustafa Ertek
Evaluation of risk factors, causative pathogens, and treatment in recurrent percutaneous nephrostomy catheter-related urinary tract infections in cancer patients. Medicine 102 (14) (2023)
Gülşen Iskender, Duygu Mert, Göknur Yapar Toros, Funda Yilmaz, Ersin Bozan, Semra Tunçbilek, Ömür Berna Çakmak Öksüzoğlu, Fevzi Altuntaş, Mustafa Ertek
COVID-19 in cancer patients: patient characteristics and outcomes in the post-COVID-19 vaccination period. Turkish journal of medical sciences 53 (6) (2023)
Gülşen Iskender, Duygu Mert, Göknur Yapar Toros, Funda Yilmaz, Ersin Bozan, Semra Tunçbilek, Ömür Berna Çakmak Öksüzoğlu, Fevzi Altuntaş, Mustafa Ertek
COVID-19 in cancer patients: patient characteristics and outcomes in the post-COVID-19 vaccination period. Turkish journal of medical sciences 53 (6) (2023)
Duygu Mert, Alparslan Merdin
Evaluation of awareness about importance of high fever in leukemia and lymphoma patients receiving chemotherapy among healthcare professionals working in pharmacies other than hospital pharmacies: A survey from a Central Anatolian city. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Duygu Mert, Muhammet Ozer, Alparslan Merdin, Gülşen İskender, Bahar Uncu Ulu, Merih Kizil Çakar, Mehmet Sinan Dal, Fevzi Altuntaş, Mustafa Ertek
Latent tuberculosis in adult hematopoietic stem cell transplantation recipients: Clinical experience from a previously endemic population. Medicine 101 (46) (2022)
Duygu Mert, Alparslan Merdin, Merih Kizil Çakar, Mehmet Sinan Dal, Fevzi Altuntaş
Evaluation of HBV, HCV, and HIV seroprevalence in patients with plasma cell disorders. Medicine 99 (34) (2020)
Alparslan Merdin, Merih Kızıl Çakar, Mehmet Sinan Dal, Duygu Mert, Jale Yıldız, Semih Başçı, Mehmet Bakırtaş, Tahir Darçın, Derya Şahin, Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Hikmettullah Batgi, Ayşegül Tetik, Dicle İskender, Fevzi Altuntaş
Evaluation of neutropenia-related outcomes in Hodgkin's lymphoma patients with moderate or severe neutropenia who received ABVD chemotherapy without using granulocyte-colony stimulating factor. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (4) (2019)
Duygu Mert, Alparslan Merdin, Sabahat Ceken, Mehmet Sinan Dal, Mustafa Ertek, Fevzi Altuntas
Development of pneumonitis after rituximab treatment in a patient with lymphoma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (4) (2019)